We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
Chagas disease is an infection caused by the “Trypanosoma cruzi” parasite which is transmitted through the bites of an insect (the “kissing bug”). The disease can also be spread from mother to child (vertical transmission), through blood transfusion, organ donation from people infected with the disease or from eating food contaminated with the parasite. For the moment, the number of new cases has been reduced thanks to policies to eliminate the insect in countries where it is endemic, as well as thanks to screening programmes aimed at blood and organ donors and pregnant women. The future challenges to cure this disease are maintaining and increasing these measures in addition to developing new treatment evolution and response markers for patients in the chronic phase, and new drugs to treat the disease.
Chagas disease is endemic to Latin America and is a global health challenge due to migration from countries in the region. Transmission via insect is mainly found in Bolivia, which has the highest number of cases. There are also infections in north-west Argentina, Peru, Paraguay, Ecuador, Nicaragua and southern Mexico. Outside these areas it is more commonly transmitted from mother to child.
Most patients with Chagas disease do not show any symptoms, which makes it difficult to detect. The disease develops in two phases:
This disease affects six to seven million people, but 60 million are estimated to be at risk of infection. There are 11,000 cases in Catalonia.
There are currently two drugs that are used to treat Chagas disease: Benznidazole and Nifurtimox. Specific treatment is needed to address any cardiac and/or gastrointestinal complications that may arise.
Since 2011, Catalonia has implemented the “Protocol for screening and diagnosing Chagas disease in pregnant Latin American women and their babies”. This programme allows possible congenital cases to be detected, and at the same time actively screens blood and organ donations from donors.
Health tips for people with chronic phase of Chagas disease
Treatment of Chagas disease
Paediatric Orthopaedic Surgery
Diagnostic and Interventional Haemodynamics
Pneumology, allergology and cystic fibrosis
Aortic pathology and Marfan syndrome
Obstetrics Ultrasound Unit
Cardiovascular Critical Care Unit
Anaesthesia, Resuscitation and Pain Management
Colon and Rectal Surgery
Physics and Radiation Protection
Paediatric Digestive Surgery and Transplants
Paediatric Oncology and Haematology
Prenatal Diagnosis Unit
Social Obstetrics Unit
Angiology, Vascular Surgery and Endovascular Surgery
General and Digestive Surgery
Gastroenterology, Hepatology, Nutritional Support and Paediatric Hepatic Transplants
Endocrine, Metabolic, and Bariatric Surgery
Physical Medicine and Rehabilitation
Corneal and Ocular Surface Section
Diabetes and Pregnancy Unit
Perinatal Mental Health Unit
Hepatobiliary and Pancreatic Surgery and Transplants
Gynaecological Oncology and Pathology of the Lower Genital Tract
Gynaecological Endoscopic Surgery
Tobacco cessation (quitting smoking)
Paediatric Maxillofacial Surgery
Haematology and Haemotherapy
Obstetric and Gynaecological Emergency Care
Preventive Medicine and Epidemiology
Congenital Heart Disease in Adolescents and Adults
Intensive care medicine
Echocardiogram and cardiac imaging unit
Uveitis and Eye Inflammation
Paediatric and Adolescent Gynaecology
Inherited Heart Disease
Strokes and Cerebral Haemodynamics
Neonatal and Foetal Surgery
Abdominal wall surgery
Endocrinology and Nutrition
Otolaryngology (Ear, Nose and Throat)
Coronary care unit
Oculoplastic and Orbital Surgery
Prematurity Prevention Unit
Paediatric Intensive Care
Plastic Surgery and Burns
Paediatric Cardiac Surgery
Paediatric Infectious Diseases and Immunodeficiencies Unit
Clinical and molecular genetics
Paediatric Hospitalisation and Hospital Paediatrics Unit
Paediatric Oncological Surgery Unit
Foetal Medicine and Surgery Unit
Thoracic Surgery and Lung Transplants
Oral and Maxillofacial Surgery
Paediatric emergency care
Hereditary Angioedema Unit
Obstetrics and Reproductive Medicine
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to firstname.lastname@example.org, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.